The investigation of BRAF inhibitors in glioma animal models showed a higher antitumor treatment efficacy in combination with MEK inhibition [81], EGFR inhibition [25] or concurrent radiotherapy [82] with longer animal survival compared to BRAF inhibition alone. This evidence concerns the gene BRAF and glioma.